Safety and efficacy of neo-adjuvant sequential dose-dense chemotherapy doublets combined with trastuzumab in patients with HER-2-positive early stage breast cancer

MeSH terms

• Adult
• Aged
• Antibodies, Monoclonal / therapeutic use*
• Antibodies, Monoclonal, Humanized
• Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
• Breast Neoplasms / drug therapy*
• Breast Neoplasms / genetics
• Breast Neoplasms / mortality
• Breast Neoplasms / pathology*
• Cohort Studies
• Disease-Free Survival
• Dose-Response Relationship, Drug
• Drug Administration Schedule
• Female
• Follow-Up Studies
• Genes, erbB-2*
• Humans
• Mastectomy / methods
• Middle Aged
• Neoadjuvant Therapy / methods*
• Neoplasm Staging
• Radiotherapy, Adjuvant
• Risk Assessment
• Survival Analysis
• Trastuzumab
• Treatment Outcome